BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 10090777)

  • 1. Development of a
    Lee JP; Corless BC; Gardner TJ; Scheinberg DA; Tan DS
    Org Lett; 2023 Sep; 25(34):6295-6299. PubMed ID: 37602700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the prodrug-activating enzyme carboxypeptidase G2 activity with chemical exchange saturation transfer magnetic resonance.
    Jamin Y; Eykyn TR; Poon E; Springer CJ; Robinson SP
    Mol Imaging Biol; 2014 Apr; 16(2):152-7. PubMed ID: 23955100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.
    Rashidi FB; AlQhatani AD; Bashraheel SS; Shaabani S; Groves MR; Dömling A; Goda SK
    PLoS One; 2018; 13(4):e0196254. PubMed ID: 29698433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.
    Yachnin BJ; Khare SD
    Protein Eng Des Sel; 2017 Apr; 30(4):321-331. PubMed ID: 28160000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a dual-function agent by fusing a designed anti-VEGF-A binder and CPG-2 enzyme.
    Etemadi A; Karimi-Jafari MH; Negahdari B; Asgari Y; Reza Khorramizadeh M; Mohammadian F; Mazloomi M
    J Biomol Struct Dyn; 2023; 41(21):11463-11470. PubMed ID: 36629035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug.
    Wang Y; Yuan H; Wright SC; Wang H; Larrick JW
    BMC Chem Biol; 2001; 1(1):4. PubMed ID: 11710971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction.
    Hensbergen AW; Buckle T; van Willigen DM; Schottelius M; Welling MM; van der Wijk FA; Maurer T; van der Poel HG; van der Pluijm G; van Weerden WM; Wester HJ; van Leeuwen FWB
    J Nucl Med; 2020 Feb; 61(2):234-241. PubMed ID: 31481575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure and mutational analysis of aminoacylhistidine dipeptidase from Vibrio alginolyticus reveal a new architecture of M20 metallopeptidases.
    Chang CY; Hsieh YC; Wang TY; Chen YC; Wang YK; Chiang TW; Chen YJ; Chang CH; Chen CJ; Wu TK
    J Biol Chem; 2010 Dec; 285(50):39500-10. PubMed ID: 20819954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs.
    Springer CJ; Niculescu-Duvaz I
    Anticancer Drug Des; 1995 Jul; 10(5):361-72. PubMed ID: 7639927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).
    Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ
    Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapy.
    Khan TH; Eno-Amooquaye EA; Searle F; Browne PJ; Osborn HM; Burke PJ
    J Med Chem; 1999 Mar; 42(6):951-6. PubMed ID: 10090777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
    Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
    J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPT.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Lehouritis P; Marais R; Springer CJ
    J Med Chem; 2003 Apr; 46(9):1690-705. PubMed ID: 12699387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide link.
    Dowell RI; Springer CJ; Davies DH; Hadley EM; Burke PJ; Boyle FT; Melton RG; Connors TA; Blakey DC; Mauger AB
    J Med Chem; 1996 Mar; 39(5):1100-5. PubMed ID: 8676345
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.